Antibodies directed against cancer stem cells could help patients with acute myeloid leukemia

Related content

• Research output

• Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy

  Research output: Contribution to journal › Article › peer-review